Furthermore, El Fatimy et al. (2018) demonstrated that miR-132 exerted neuroprotective effects for AD through multiple signaling pathways; miR-132 could eliminate multiple forms of tau protein implicated in tauopathies. Here, MAPT is linked to Alzheimer disease.